Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel disease mainly comprises of Ulcerative colitis and Crohn’s disease. The ulcerative colitis primarily affects the large intestine and anus and it causes the inflammation sores in the inner lining of colon and rectum. The Crohn’s disease affects any part of gastrointestinal tract and unlike ulcerative colitis, it affects all the layers of gastrointestinal walls. The ulcerative colitis is more prevalent than that of Crohn’s disease. The IBD affects equally in men and women and has prevalence and incidence rates in developed countries than that of developing and under developed countries. The exact cause of inflammatory bowel disease are not well understood however, the combination of several factors such as autoimmune disorders, genetic factors, lifestyle related risks factors such as smoking, sedentary lifestyle, lack of exercise are likely to contribute to the development of symptoms of inflammatory bowel disease. The common symptoms of inflammatory bowel disease includes the severe abdominal cramps and pain, persistent diarrhea, occasional rectal bleeding.
The IBD has no permanent cure and requires the lifelong disease management and treatment. Several medications such as corticosteroids, aminosalicyclates, immunomodulators, and biologic drugs such as TNF inhibitors and up to certain extent antibiotic drugs are prescribed to relive the symptoms of these diseases.
Market Analysis and Insights: Global Inflammatory Bowel Disease (IBD) Treatment Market
The global Inflammatory Bowel Disease (IBD) Treatment market size is projected to reach US$ 13640 million by 2026, from US$ 13310 million in 2020, at a CAGR of 2.3%% during 2021-2026.
Global Inflammatory Bowel Disease (IBD) Treatment Scope and Market Size
Inflammatory Bowel Disease (IBD) Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inflammatory Bowel Disease (IBD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
AbbVie
Pfizer
Takeda
Janssen Biotech, Inc. (Johnson & Johnson)
Allergan
Bausch Health
Takeda Pharmaceutical
Novartis
Biogen Inc.
Inflammatory Bowel Disease (IBD) Treatment Breakdown Data by Type
TNF Inhibitors
Aminosalicyclates
Immunomodulators
Corticosteroids
Inflammatory Bowel Disease (IBD) Treatment Breakdown Data by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
The IBD has no permanent cure and requires the lifelong disease management and treatment. Several medications such as corticosteroids, aminosalicyclates, immunomodulators, and biologic drugs such as TNF inhibitors and up to certain extent antibiotic drugs are prescribed to relive the symptoms of these diseases.
Market Analysis and Insights: Global Inflammatory Bowel Disease (IBD) Treatment Market
The global Inflammatory Bowel Disease (IBD) Treatment market size is projected to reach US$ 13640 million by 2026, from US$ 13310 million in 2020, at a CAGR of 2.3%% during 2021-2026.
Global Inflammatory Bowel Disease (IBD) Treatment Scope and Market Size
Inflammatory Bowel Disease (IBD) Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Inflammatory Bowel Disease (IBD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The following players are covered in this report:
AbbVie
Pfizer
Takeda
Janssen Biotech, Inc. (Johnson & Johnson)
Allergan
Bausch Health
Takeda Pharmaceutical
Novartis
Biogen Inc.
Inflammatory Bowel Disease (IBD) Treatment Breakdown Data by Type
TNF Inhibitors
Aminosalicyclates
Immunomodulators
Corticosteroids
Inflammatory Bowel Disease (IBD) Treatment Breakdown Data by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Inflammatory Bowel Disease (IBD) Treatment Revenue
1.4 Market by Type
1.4.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 TNF Inhibitors
1.4.3 Aminosalicyclates
1.4.4 Immunomodulators
1.4.5 Corticosteroids
1.5 Market by Application
1.5.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Perspective (2015-2026)
2.2 Global Inflammatory Bowel Disease (IBD) Treatment Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Inflammatory Bowel Disease (IBD) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Inflammatory Bowel Disease (IBD) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Inflammatory Bowel Disease (IBD) Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Market Size
3.1.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Revenue (2015-2020)
3.1.2 Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio
3.2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease (IBD) Treatment Revenue in 2019
3.3 Inflammatory Bowel Disease (IBD) Treatment Key Players Head office and Area Served
3.4 Key Players Inflammatory Bowel Disease (IBD) Treatment Product Solution and Service
3.5 Date of Enter into Inflammatory Bowel Disease (IBD) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
5.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
6.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in North America (2019-2020)
6.3 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
6.4 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
7.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Europe (2019-2020)
7.3 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
7.4 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
8 China
8.1 China Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
8.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in China (2019-2020)
8.3 China Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
8.4 China Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
9.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Japan (2019-2020)
9.3 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
9.4 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
10.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
11 India
11.1 India Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
11.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in India (2019-2020)
11.3 India Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
11.4 India Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
12.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Inflammatory Bowel Disease (IBD) Treatment Introduction
13.1.4 AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Inflammatory Bowel Disease (IBD) Treatment Introduction
13.2.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Takeda
13.3.1 Takeda Company Details
13.3.2 Takeda Business Overview
13.3.3 Takeda Inflammatory Bowel Disease (IBD) Treatment Introduction
13.3.4 Takeda Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.3.5 Takeda Recent Development
13.4 Janssen Biotech, Inc. (Johnson & Johnson)
13.4.1 Janssen Biotech, Inc. (Johnson & Johnson) Company Details
13.4.2 Janssen Biotech, Inc. (Johnson & Johnson) Business Overview
13.4.3 Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Introduction
13.4.4 Janssen Biotech, Inc. (Johnson & Johnson) Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.4.5 Janssen Biotech, Inc. (Johnson & Johnson) Recent Development
13.5 Allergan
13.5.1 Allergan Company Details
13.5.2 Allergan Business Overview
13.5.3 Allergan Inflammatory Bowel Disease (IBD) Treatment Introduction
13.5.4 Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.5.5 Allergan Recent Development
13.6 Bausch Health
13.6.1 Bausch Health Company Details
13.6.2 Bausch Health Business Overview
13.6.3 Bausch Health Inflammatory Bowel Disease (IBD) Treatment Introduction
13.6.4 Bausch Health Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.6.5 Bausch Health Recent Development
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Company Details
13.7.2 Takeda Pharmaceutical Business Overview
13.7.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Introduction
13.7.4 Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.7.5 Takeda Pharmaceutical Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Inflammatory Bowel Disease (IBD) Treatment Introduction
13.8.4 Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Biogen Inc.
13.9.1 Biogen Inc. Company Details
13.9.2 Biogen Inc. Business Overview
13.9.3 Biogen Inc. Inflammatory Bowel Disease (IBD) Treatment Introduction
13.9.4 Biogen Inc. Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.9.5 Biogen Inc. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Inflammatory Bowel Disease (IBD) Treatment Revenue
1.4 Market by Type
1.4.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 TNF Inhibitors
1.4.3 Aminosalicyclates
1.4.4 Immunomodulators
1.4.5 Corticosteroids
1.5 Market by Application
1.5.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Perspective (2015-2026)
2.2 Global Inflammatory Bowel Disease (IBD) Treatment Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease (IBD) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Inflammatory Bowel Disease (IBD) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Inflammatory Bowel Disease (IBD) Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Inflammatory Bowel Disease (IBD) Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Market Size
3.1.1 Global Top Inflammatory Bowel Disease (IBD) Treatment Players by Revenue (2015-2020)
3.1.2 Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Inflammatory Bowel Disease (IBD) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio
3.2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease (IBD) Treatment Revenue in 2019
3.3 Inflammatory Bowel Disease (IBD) Treatment Key Players Head office and Area Served
3.4 Key Players Inflammatory Bowel Disease (IBD) Treatment Product Solution and Service
3.5 Date of Enter into Inflammatory Bowel Disease (IBD) Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Inflammatory Bowel Disease (IBD) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
5.2 Global Inflammatory Bowel Disease (IBD) Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
6.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in North America (2019-2020)
6.3 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
6.4 North America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
7.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Europe (2019-2020)
7.3 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
7.4 Europe Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
8 China
8.1 China Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
8.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in China (2019-2020)
8.3 China Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
8.4 China Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
9.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Japan (2019-2020)
9.3 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
9.4 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
10.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
11 India
11.1 India Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
11.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in India (2019-2020)
11.3 India Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
11.4 India Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size (2015-2020)
12.2 Inflammatory Bowel Disease (IBD) Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size by Type (2015-2020)
12.4 Central & South America Inflammatory Bowel Disease (IBD) Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview
13.1.3 AbbVie Inflammatory Bowel Disease (IBD) Treatment Introduction
13.1.4 AbbVie Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Inflammatory Bowel Disease (IBD) Treatment Introduction
13.2.4 Pfizer Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Takeda
13.3.1 Takeda Company Details
13.3.2 Takeda Business Overview
13.3.3 Takeda Inflammatory Bowel Disease (IBD) Treatment Introduction
13.3.4 Takeda Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.3.5 Takeda Recent Development
13.4 Janssen Biotech, Inc. (Johnson & Johnson)
13.4.1 Janssen Biotech, Inc. (Johnson & Johnson) Company Details
13.4.2 Janssen Biotech, Inc. (Johnson & Johnson) Business Overview
13.4.3 Janssen Biotech, Inc. (Johnson & Johnson) Inflammatory Bowel Disease (IBD) Treatment Introduction
13.4.4 Janssen Biotech, Inc. (Johnson & Johnson) Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.4.5 Janssen Biotech, Inc. (Johnson & Johnson) Recent Development
13.5 Allergan
13.5.1 Allergan Company Details
13.5.2 Allergan Business Overview
13.5.3 Allergan Inflammatory Bowel Disease (IBD) Treatment Introduction
13.5.4 Allergan Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.5.5 Allergan Recent Development
13.6 Bausch Health
13.6.1 Bausch Health Company Details
13.6.2 Bausch Health Business Overview
13.6.3 Bausch Health Inflammatory Bowel Disease (IBD) Treatment Introduction
13.6.4 Bausch Health Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.6.5 Bausch Health Recent Development
13.7 Takeda Pharmaceutical
13.7.1 Takeda Pharmaceutical Company Details
13.7.2 Takeda Pharmaceutical Business Overview
13.7.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Introduction
13.7.4 Takeda Pharmaceutical Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.7.5 Takeda Pharmaceutical Recent Development
13.8 Novartis
13.8.1 Novartis Company Details
13.8.2 Novartis Business Overview
13.8.3 Novartis Inflammatory Bowel Disease (IBD) Treatment Introduction
13.8.4 Novartis Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.8.5 Novartis Recent Development
13.9 Biogen Inc.
13.9.1 Biogen Inc. Company Details
13.9.2 Biogen Inc. Business Overview
13.9.3 Biogen Inc. Inflammatory Bowel Disease (IBD) Treatment Introduction
13.9.4 Biogen Inc. Revenue in Inflammatory Bowel Disease (IBD) Treatment Business (2015-2020)
13.9.5 Biogen Inc. Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
